BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,313 | -22.4% | 285 | -2.4% | 0.00% | – |
| Q2 2023 | $18,454 | +142.7% | 292 | +72.8% | 0.00% | – |
| Q1 2023 | $7,603 | +48.3% | 169 | +44.4% | 0.00% | – |
| Q4 2022 | $5,126 | -60.6% | 117 | -42.1% | 0.00% | – |
| Q3 2022 | $13,000 | 0.0% | 202 | -23.2% | 0.00% | – |
| Q2 2022 | $13,000 | +44.4% | 263 | +89.2% | 0.00% | – |
| Q1 2022 | $9,000 | -18.2% | 139 | +29.9% | 0.00% | – |
| Q4 2021 | $11,000 | +22.2% | 107 | +18.9% | 0.00% | – |
| Q3 2021 | $9,000 | +12.5% | 90 | +2.3% | 0.00% | – |
| Q2 2021 | $8,000 | 0.0% | 88 | +1.1% | 0.00% | – |
| Q1 2021 | $8,000 | -20.0% | 87 | +1.2% | 0.00% | – |
| Q4 2020 | $10,000 | +25.0% | 86 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | +60.0% | 86 | +30.3% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 66 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | – | 66 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |